Literature DB >> 2974508

Blood transfusion in renal transplantation--the induction of tolerance by incompatibility for class I antigen.

D Bućin1.   

Abstract

Blood transfusion given before renal transplantation has been shown to have a powerful immune modulating effect on recipient response to kidney allograft. The mechanism responsible for this effect is still unknown. Here it is assumed that, due to incompatibility for HLA-A related class I antigens between blood donor and recipient, pretransplant blood transfusion may allospecifically induce in the recipient the generation of T cells that have a suppressive effect on T lymphocyte response to incompatible HLA class II antigens present on kidney allograft. Although in many respects this interpretation is still speculative, it is in accord with findings reported from clinical and experimental studies of the effect on graft survival of blood transfusion, both random and donor specific.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2974508     DOI: 10.1016/0306-9877(88)90077-1

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection.

Authors:  Shusen Wang; Xiaomin Zhang; Lei Zhang; Jane Bryant; Taba Kheradmand; Bernhard J Hering; Stephen D Miller; Xunrong Luo
Journal:  Cell Transplant       Date:  2014-04-22       Impact factor: 4.064

2.  Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance.

Authors:  Taba Kheradmand; Shusen Wang; Jane Bryant; James J Tasch; Nadine Lerret; Kathryn L Pothoven; Josetta L Houlihan; Stephen D Miller; Zheng J Zhang; Xunrong Luo
Journal:  J Immunol       Date:  2012-06-13       Impact factor: 5.422

3.  Analysis of the Influence of HLA-A Matching Relative to HLA-B and -DR Matching on Heart Transplant Outcomes.

Authors:  David Ansari; Dragan Bućin; Peter Höglund; Mattias Ohlsson; Bodil Andersson; Johan Nilsson
Journal:  Transplant Direct       Date:  2015-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.